Five months after giving up on its lead drug Betalutin for follicular lymphoma, Nordic Nanovector has charted a course forward via a merger with fellow Norwegian biotech APIM Therapeutics.

Royal, vintage, Gothic horizontal background in red with a classic Baroque pattern, Rococo.With dimming at the edges Vector seamless pattern Vector seamless dark pattern with golden ornament. Ornate ...